Loss of RELN expression has indeed been shown to induce cell migration in esophageal carcinoma, and to be associated with poor prognosis in breast cancer (Stein et al., 2010; Yuan et al., 2012). This evidence concerns the gene RELN and carcinoma of esophagus.